InMed Pharmaceuticals to Present at BIO Investor Forum on October 17, 2018

This information was provided by prnewswire

Send your Press Release here.

TSX: IN
OTCQX: IMLFF

VANCOUVER, Oct. 10, 2018 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, will be presenting at the BIO Investor Forum on Wednesday, October 17, 2018 at 9:30 AM PT / 12:30 PM ET at the Westin St. Francis, in San Francisco, California. The presentation will be webcast, the link to which may be found on the Company’s website, or below.

Conference Call & Webcast:
Wednesday, Oct. 17, 2018 at 9:30 AM Pacific Time, 12:30 PM Eastern Time